A Breakthrough in Veterinary Emergency Medicine: Refrigerated Canine Platelets Offer New Hope for Hemorrhage Control

In a landmark development for veterinary emergency and critical care, a study conducted by the Washington State University (WSU) College of Veterinary Medicine has provided the first clinical evidence that refrigerated canine platelets, stored for up to three weeks, can effectively control or prevent life-threatening hemorrhages. This finding, recently published in the Journal of Veterinary Internal Medicine, challenges long-held standards in veterinary hematology and promises to transform how clinics manage patients suffering from severe thrombocytopenia.

For decades, the standard for platelet transfusion has been cumbersome and limiting. Conventional canine platelet concentrates are typically stored at room temperature under constant agitation, a practice that restricts their shelf life to a mere five days. This short window not only creates logistical hurdles for veterinary blood banks but also increases the risk of bacterial contamination, further complicating the care of critically ill dogs. The WSU research suggests that a shift toward cold-storage protocols could provide a more reliable, safer, and more accessible lifeline for veterinary patients.

The Chronic Challenge of Platelet Transfusions

Platelet transfusions are often the difference between life and death for dogs suffering from severe thrombocytopenia—a condition characterized by an abnormally low platelet count. Whether caused by immune-mediated destruction, bone marrow failure, or consumption during trauma, the inability of blood to clot leads to devastating hemorrhages.

Despite the critical nature of these cases, platelet therapy has historically been underused in veterinary medicine, primarily due to the "five-day shelf life" bottleneck. Dr. Jillian Haines, DVM, MS, DACVIM (SAIM), director of the WSU Veterinary Teaching Hospital’s blood bank and the lead researcher on the study, describes the situation as a historical frustration for clinicians.

"It is hard to overstate how important the ability to transfuse platelets is," Dr. Haines noted. "Many of us have seen patients die from bleeding complications because there was simply nothing we could offer them. We went from having essentially nothing available to now having a really viable product that we can use."

Study Design: Rigorous Clinical Evaluation

To investigate the efficacy of cold-stored platelets, the WSU research team conducted a retrospective analysis of medical records from the WSU Veterinary Teaching Hospital. The study encompassed 24 dogs with varying degrees of thrombocytopenia who received a total of 27 cold-stored platelet transfusions between March 2022 and October 2024.

The methodology for preparing these products was designed for practical implementation. Platelet concentrates were derived from 450-mL whole blood donations using a double-centrifugation process. Once isolated, the platelets were stored at 4°C—the same temperature used for human blood banking—without the need for constant agitation. The mean storage duration for the units used in the study was 12.4 days, significantly exceeding the conventional five-day room-temperature limit.

The patient cohort was diverse, reflecting the realities of emergency medicine. Immune-mediated thrombocytopenia (IMT) was the most common primary diagnosis (n=9), followed by various forms of neoplasia (n=7). The transfusions were administered for three distinct clinical scenarios:

1. Surgical support: To prevent excessive bleeding during invasive procedures (n=6).
2. Spontaneous bleeding: To address active, life-threatening hemorrhage (n=9).
3. Minimally invasive diagnostic procedures: To mitigate risk in patients with low platelet counts (n=12).

To measure efficacy, the researchers utilized a modified version of the Daily Canine Bleeding Assessment Tool (DOGiBAT), with the addition of a specific category for "cavitary bleeding." Hemorrhage severity was scored at baseline and at one-hour and four-hour intervals following the transfusion.

Key Findings: Clotting Function Over Count

The results of the study were striking. Clinical improvement was observed in 70% of the transfusion events (19 out of 27) within just four hours, with partial improvement noted in another 26%. The mean modified DOGiBAT scores decreased from 3.15 at baseline to 2.21 at the four-hour mark, representing a statistically significant improvement (P = .002).

Interestingly, the study found that the absolute platelet count in the recipients did not rise significantly following the transfusion—a finding that might seem counterintuitive to the layperson. However, the researchers emphasized that this was an expected outcome.

"Cold-stored platelets circulate briefly," the study authors noted, "but they retain, and may even enhance, their clot-forming function." In the context of emergency medicine, the biological ability of the platelets to plug a vessel wall and facilitate hemostasis is far more critical than the laboratory measurement of the circulating platelet count.

Safety was another pillar of the study’s success. No transfusion reactions were documented among the participants. Furthermore, 79% of the dogs (19 of 24) survived to discharge. The researchers noted that the dogs who did not survive suffered from more severe bleeding at baseline, suggesting that while the product is highly effective, the timing of the intervention remains paramount. Additionally, three dogs experienced delayed bleeding 12 to 24 hours after their procedures, indicating that some patients may require repeat dosing, a factor that will inform future clinical protocols.

Practical Advantages for the Modern Blood Bank

The transition to a cold-storage model offers profound operational benefits for veterinary institutions. Beyond the extension of the shelf life from five days to three weeks, cold-stored platelets offer several logistical advantages:

• Resistance to Bacterial Growth: By storing platelets at 4°C, the risk of bacterial proliferation—a significant concern with room-temperature storage—is drastically reduced.
• Reduced Equipment Needs: The elimination of the requirement for constant agitation simplifies storage requirements, allowing clinics to use standard refrigeration equipment.
• Ease of Transport: Because these products are more stable, they can be shipped more easily between institutions, potentially expanding the reach of advanced care to rural or smaller veterinary practices.

Dr. Haines has already begun translating these findings into practice at WSU, where the blood bank now maintains a routine supply of cold-stored platelets. Furthermore, she has taken an active role in training veterinary personnel from other institutions on the processing and application techniques, signaling a potential shift in the standard of care across the broader veterinary community.

Limitations and Future Directions

While the findings are encouraging, the research team remains professionally cautious. Because the study was retrospective, the researchers had limited control over the timing of transfusions and the administration of concurrent treatments. Furthermore, nine of the dogs involved in the study received other blood products, which could potentially confound the results. The absence of a room-temperature control group and the use of a non-validated scoring tool (the modified DOGiBAT) are areas that future studies will need to address.

Dr. Haines has already outlined an ambitious research agenda to build on these initial findings. Future investigations will focus on:

• Optimal Dosing Protocols: Determining the most effective volume and frequency for different patient populations.
• Measuring Efficacy: Developing more precise, real-time methods to quantify the effectiveness of platelet function in individual patients.
• Extended Storage Research: Evaluating whether the platelets remain effective for periods exceeding three weeks.

Implications for Veterinary Medicine

The WSU study represents a paradigm shift. For years, the limitations of platelet storage have acted as a barrier to effective care, often forcing veterinarians to make difficult decisions when confronted with bleeding patients.

"It’s not needed often," Dr. Haines remarked, "but when it is needed, it is the only option. These products can be lifesaving."

As the profession moves toward integrating these findings, the ability to maintain a ready-to-use supply of platelets could redefine the scope of emergency surgery and critical care in veterinary medicine. By removing the logistical "ticking clock" of the five-day storage limit, this breakthrough ensures that when a patient arrives in crisis, the tools for survival are more likely to be waiting on the shelf.

For the veterinary community, this study serves as a poignant reminder that even minor adjustments in storage protocols can lead to major advancements in patient outcomes. As further research validates these techniques, the future of canine emergency medicine looks significantly brighter—and much better prepared to stop the bleeding.